KBN-Zhejiang Pharmaceutical

Zhejiang KBN Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the development and commercialization of transdermal drug delivery systems (TDDS). The company leverages its proprietary technology platform to create advanced patch formulations for chronic conditions, particularly in pain management, neurology, and cardiovascular medicine. Its product portfolio includes high-barrier generic and innovative transdermal patches such as fentanyl, buprenorphine, and rivastigmine. KBN operates state-of-the-art manufacturing facilities that comply with international GMP standards, positioning itself as a leader in the Chinese transdermal market. The company also provides CDMO services for topical and transdermal products to global partners.